Long-Acting HIV Treatment in Low- and Middle-Income Countries
This Viewpoint discusses the need to develop products, such as long-acting antiretrovirals, for people with HIV in settings with minimal resource requirements.
Authors
- Peter Ehrenkranz (ORCID: https://orcid.org/0000-0003-2028-4779)
- Michael Reid (ORCID: https://orcid.org/0000-0001-6777-9619)
- Peter S. Kim (ORCID: https://orcid.org/0000-0001-6503-4541)
- Meg Doherty (ORCID: https://orcid.org/0000-0003-2986-7129)
Institutions
- National Institutes of Health (US)
- Gates Foundation (US)
- World Health Organization (CH)
- President's Emergency Plan for AIDS Relief (US)
- National Institute of Allergy and Infectious Diseases (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1001/jama.2025.5180
- Citations
- 2
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 2.79